PMID- 27919096
OWN - NLM
STAT- MEDLINE
DCOM- 20170427
LR  - 20210319
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 165
IP  - 11
DP  - 2016 Dec 6
TI  - Should We Screen for Vitamin D Deficiency?: Grand Rounds Discussion From Beth 
      Israel Deaconess Medical Center.
PG  - 800-807
LID - 10.7326/M16-1993 [doi]
AB  - The U.S. Preventive Services Task Force (USPSTF) recently issued guidelines on 
      screening for vitamin D deficiency. The guidelines were based on randomized 
      trials of vitamin D deficiency screening and treatment, as well as on 
      case-control studies nested within the Women's Health Initiative. The USPSTF 
      concluded that current evidence is insufficient to assess the benefits and harms 
      of screening for vitamin D deficiency in asymptomatic adults. Compared with 
      placebo or no treatment, vitamin D was associated with decreased mortality; 
      however, benefits were no longer seen after trials of institutionalized persons 
      were excluded. Vitamin D treatment was associated with a possible decreased risk 
      for at least 1 fall and the total number of falls per person but not for 
      fractures. None of the studies examined the effects of vitamin D screening versus 
      not screening on clinical outcomes. In this Grand Rounds, 2 prominent 
      endocrinologists debate the issue of screening for vitamin D deficiency in a 
      55-year-old, asymptomatic, postmenopausal woman. They review the data on which 
      the USPSTF recommendations are based and discuss the potential benefits and 
      risks, as well as the challenges and controversies, of screening for vitamin D 
      deficiency in primary care practice.
FAU - Libman, Howard
AU  - Libman H
FAU - Malabanan, Alan O
AU  - Malabanan AO
FAU - Strewler, Gordon J
AU  - Strewler GJ
FAU - Reynolds, Eileen E
AU  - Reynolds EE
LA  - eng
PT  - Clinical Conference
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
RN  - 1406-16-2 (Vitamin D)
SB  - IM
MH  - Dietary Supplements
MH  - Female
MH  - Humans
MH  - *Mass Screening
MH  - Middle Aged
MH  - Postmenopause
MH  - *Practice Guidelines as Topic
MH  - Risk Assessment
MH  - Vitamin D/therapeutic use
MH  - Vitamin D Deficiency/complications/*diagnosis/drug therapy
EDAT- 2016/12/06 06:00
MHDA- 2017/04/28 06:00
CRDT- 2016/12/06 06:00
PHST- 2016/12/06 06:00 [entrez]
PHST- 2016/12/06 06:00 [pubmed]
PHST- 2017/04/28 06:00 [medline]
AID - 2590900 [pii]
AID - 10.7326/M16-1993 [doi]
PST - ppublish
SO  - Ann Intern Med. 2016 Dec 6;165(11):800-807. doi: 10.7326/M16-1993.